PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

The engagement with Dr Reddy's utilised PharmaVentures' significant and established pharmaceutical transactions experience in the healthcare transactions sector. Dr Fintan Walton, Chief Executive, PharmaVentures said, "We are delighted to bring another successful outcome to one of our important international clients, Dr Reddy's. We are proud to have acted as advisor and broker to one of India's premier pharmaceutical companies, particularly in assisting them to achieve their business goals in the increasingly expanding Russian/CIS market."

PharmaVentures acted as advisor and broker to the Dow Chemical Corporation in the sale of its small molecule pharmaceutical manufacturing business to Dr Reddy's, under a separate agreement in 2008.

Over the past 18 years, PharmaVentures has acted as advisors to numerous pharmaceutical and biopharmaceutical clients in transactions covering the licensing, merger, acquisition, divestment and joint venture activities for companies located worldwide.

SOURCE PharmaVentures

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Vitabiotics Ltd.. (2010, October 26). PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics. News-Medical. Retrieved on May 24, 2024 from https://www.news-medical.net/news/20101026/PharmaVentures-acts-as-advisor-and-broker-to-Dr-Reddys-in-distribution-agreement-with-Vitabiotics.aspx.

  • MLA

    Vitabiotics Ltd.. "PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics". News-Medical. 24 May 2024. <https://www.news-medical.net/news/20101026/PharmaVentures-acts-as-advisor-and-broker-to-Dr-Reddys-in-distribution-agreement-with-Vitabiotics.aspx>.

  • Chicago

    Vitabiotics Ltd.. "PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics". News-Medical. https://www.news-medical.net/news/20101026/PharmaVentures-acts-as-advisor-and-broker-to-Dr-Reddys-in-distribution-agreement-with-Vitabiotics.aspx. (accessed May 24, 2024).

  • Harvard

    Vitabiotics Ltd.. 2010. PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics. News-Medical, viewed 24 May 2024, https://www.news-medical.net/news/20101026/PharmaVentures-acts-as-advisor-and-broker-to-Dr-Reddys-in-distribution-agreement-with-Vitabiotics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.